ClinicalTrials.Veeva

Menu

Early Endoscopic Indicators for OACs After Lung Transplantation: Development of a Novel Mucosal Healing Score

T

Thomas Fuehner

Status

Completed

Conditions

Airway Complication Which Require Any Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT00940147
OAC_1.0
2008_01

Details and patient eligibility

About

Airway complications are a significant cause of morbidity after lung transplantation (LTx). Bronchoscopic evaluation may help to identify risk factors for requiring interventions later.

Full description

The investigators evaluated lung transplant recipients prospectively. Adult patients surviving 90 day after LTx will be included. The investigators propose a classification of airway healing based on the endoscopic bronchial appearances at days 7, 14, 21, 90, 180 and 365 after LTx. A score system including mucosal healing, full tissue necrosis (=dehiscence), lose sutures, fibrin plugs, polyps and malacia will be developed (max. score 8 points/date). Endoscopic findings will be correlated with the development of obstructive airway complications (OAC, requiring >1 intervention). Afterwards the new score system will be applied prospectively in the patients.

Enrollment

180 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 3 month survivor after LTx
  • no OAC

Exclusion criteria

Trial design

180 participants in 2 patient groups

1
Description:
patients with OAC, Score finding
2
Description:
patients without OAC, Score finding

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems